Testo completo - Associazione Italiana di Aritmologia e ...

Bibliografia
1) Brignole M, Alboni P, Benditt DG, et al.: for the Task Force on
Sincope, European Society of Cardiology. Guidelines on management
(diagnosis and treatment) of syncope – update 2004.
Europace 2004; 6: 467-537.
2) Brignole M: Neurally-mediated syncope. Ital Heart J 2005; 6:
249-255.
3) Fitzpatrick A, Theodorakis G, Ahmed R, et al.: Dual chamber
pacing aborts vasovagal syncope induced by head-up 60 degree
tilt. Pacing Clin Electrophysiol 1991; 14: 13-9.
4) Sra J, Jazayeri MR, Avitall B, et al.: Comparison of cardiac pacing
with drug therapy in the treatment of neurocardiogenic (vasovagal)
syncope with bradycardia or asystole. N Engl J med 1993;
328: 1085-90.
5) Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al.:
Permanent pacing for cardio-inhibitory malignant vasovagal syndrome.
Br Heart J 1994; 71: 274-81.
6) El-Bedawi KM, Wahbha MMMAE, Hainsworth R. Cardiac pacing
does not improve orthostatic tolerance in patients with vasovagal
syncope. Clin Autonom Res 1995; 88: 463-70.
7) Benditt DG, Pedresen M, Lurie KG, et al.: Cardiac pacing for
prevention of recurrent vasovagal syncope. Ann Int Med 1995;
122: 204-9.
8) Benditt DG, Sutton R, Gammage M, et al.: Rate-Drop Response
Investigators Group. Rate-drop response cardiac pacing for vasovagal
syncope. J Intervent Cardiac Electrophys 1999; 3: 27-33.
9) Connolly SJ, Sheldon R, Roberts RS, et al.: Vasovagal pacemaker
study investigators. The North American vasovagal pacemaker
study (VPS): A randomized trial of permanent cardiac
pacing for the prevention of vasovagal syncope. J Am Coll Cardiol
1999; 33: 16-20.
10) Sutton R, Brignole M, Menozzi C, et al.: Dual-chamber pacing
in treatment of neurally-mediated tilt-positive cardioinhibitory
syncope. Pacemaker versus no therapy: a multicentre randomized
study. The Vasovagal Syncope International Study (VASIS)
Investigators. Circulation 2000; 102: 294-9.
11) Ammirati F, Colivicchi F, Santini M, et al.: Permanent Cardiac
Pacing versus medical treatment for the prevention of recurrent
vasovagal sincope. A multicenter, randomized, controlled trial.
Circulation 2001; 104: 52-7.
12) Connolly SJ, Sheldon R, Thorpe KE, et al.: for the VPS II investigators.
Pacemaker therapy for the prevention of syncope in
patients with recurrent severe vasovagal syncope: Second
Vasovagal Pacemaker Study (VPS II). JAMA 2003; 289: 2224-
9.
13) Raviele A, Giada F, Menozzi C, et al; Vasovagal Syncope and
Pacing Trial Investigators. A randomized, double-blind, placebo-controlled
study of permanent cardiac pacing for the treat-
GIAC • Volume 8 • Numero 4 • Dicembre 2005
22
ment of recurrent tilt-induced vasovagal syncope. The vasovagal
syncope and pacing Trial (SYNPACE). Eur Heart J 2004;
25: 1741-8.
14) Gregoratos G, Abrams J, Epstein AE, et al.: American College
of Cardiology/American Heart Association Task Force on Practice
Guidelines/North American Society for Pacing and
Electrophysiology Committee to Update the 1998 Pacemaker
Guidelines. ACC/AHA/NASPE 2002 guideline update for
implantation of cardiac pacemakers and antiarrhythmia devices:
summary article: a report of the American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines (ACC/AHA/NASPE Committee to Update the 1998
Pacemaker Guidelines). Circulation 2002; 106: 2145-61.
15) Thomas JE: Hyperactive carotid sinus reflex and carotid sinus
syncope. Mayo Clin Proc 1969; 44: 127-39.
16) Brignole M, Menozzi C, Lolli G, et al.: Validation of a method
for choice of pacing mode in carotid sinus sindrome with or
without sinus bradicardia. Pacing Clin Electrophysiol 1991; 14:
196-203.
17) Brignole M, Menozzi M, Lolli G, et al.: Long-term outcome of
paced and non paced patients with severe carotid sinus sindrome.
Am J Cardiol 1992; 69: 1039-43.
18) Menozzi C, Brignole M, Lolli G, et al.: Follow-up of asystolic
episodes in patients with cardioinhibitory neurally mediated syncope
and VVI pacemaker. Am J Cardiol 1993; 72: 1152-5.
19) Morley CA, Perrins EJ, Grant PL, et al.: Carotid sinus syncope
treated by pacing. Analysis of persistent symptoms and role of
atrio ventricular sequential pacing. Br Heart J 1982; 47: 411-
8.
20) Sugrue DD, Gersh BJ, Holmes DR, et al.: Symptomatic “isolated”
carotid sinus hypersensitivity: Natural history and results
of treatment with anticholinergic drugs or pacemaker. J Am Coll
Cardiol 1986; 7: 158-62.
21) Madigan NP, Flaker GC, Cutis JJ, et al.: Carotid sinus hypersensitivity:
Beneficial effects of dual-chamber pacing. Am J
Cardiol 1984; 53: 1034-40.
22) Brignole M, Sartore B, Barra M, et al.: Is DDD superior to VVI
pacing in mixed carotid sinus sindrome ? An acute and medium-term
study. Pacing Clin Electrophysiol 1988; 11: 1902-10.
23) Brignole M, Sartore B, Barra M, et al.: Ventricular and dual
chamber pacing for treatment of carotid sinus syndrome. Pacing
Clin Electrophysiol 1989; 12: 582-90.
24) Deschamps D, Richard A, Citron B, et al.: Hypersensibilite sinocarotidienne.
Evolution a moyen et a long terme des patients
traites par stimulation ventriculaire. Arch Mal Cœur 1990; 83:
63-7.
25) Brignole M, Menozzi C, Gianfranchi L, et al.: Carotid sinus massage,
eyeball compression and head-up tilt test in patients with
syncope of uncertain origin and in healthy control subjects. Am
Heart J 1991; 122: 1644-51